Composition for preventing or treating colorectal cancer comprising mixed strain of probiotics
AssigneeMediogen Co., Ltd.
InventorsNam Soo Paek, Chang Ho Kang
Life of this patent
Estimating the term…
Abstract
Provided is a composition for preventing or treating colorectal cancer including a mixed strain of probiotics as an active ingredient, specifically, a composition for preventing, alleviating or treating colorectal cancer including a mixed killed strain of L. casei, L. reuteri or Bi. bifidum. According to the present disclosure, the composition is confirmed to have excellent effects of activating apoptosis-related signaling molecules in colorectal cancer cells and inhibiting the growth of tumors derived from colorectal cancer cells, and thus may be usefully used in various industrial fields such as medicines and foods, for prevention, alleviation, or treatment of colorectal cancer.
Claims14
A method for alleviating or treating colorectal cancer, comprising:
- administering a composition, to a subject, including a mixture of a killed strain of L. casei MG4584 (accession number:
- KCTC14423BP) and a killed strain of L. reuteri MG5346 (accession number:
- KCTC14507BP) or a culture thereof.
A method for preparing a composition for alleviating or treating colorectal cancer, comprising:
- mixing heat-killed strains,
- wherein the strains are L. casei MG4584 (accession number:
- KCTC14423BP) and L. reuteri MG5346 (accession number:
- KCTC14507BP).
Dependencies are inferred from the claim text.